Literature DB >> 15956644

Trastuzumab trials steal show at ASCO meeting.

Rabiya S Tuma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15956644     DOI： 10.1093/jnci/97.12.870

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  8 in total

1.  Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer.

Authors:  Stefan S Bozhanov; Svetla G Angelova; Maria E Krasteva; Tsanko L Markov; Svetlana L Christova; Ivan G Gavrilov; Elena I Georgieva
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-23       Impact factor: 4.553

2.  Analysis of HER2 gene amplification and protein expression in esophageal squamous cell carcinoma.

Authors:  Na Zhan; Wei-Guo Dong; Yong-Fei Tang; Ze-Sheng Wang; Cheng-Long Xiong
Journal:  Med Oncol       Date:  2011-02-13       Impact factor: 3.064

3.  Human epidermal growth factor receptor-2 gene amplification in gastric cancer using tissue microarray technology.

Authors:  Dimitrios Tsapralis; Ioannis Panayiotides; George Peros; Theodore Liakakos; Eva Karamitopoulou
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

4.  [HER2 ASCO guidelines. The answer to everything?].

Authors:  E Burandt; G Sauter
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

5.  Media Hyping and the "Herceptin Access Story": An Analysis of Canadian and UK Newspaper Coverage.

Authors:  Julia Abelson; Patricia A Collins
Journal:  Healthc Policy       Date:  2009-02

6.  The impact of androgen receptor expression on breast cancer survival: a retrospective study and meta-analysis.

Authors:  Qing Qu; Yan Mao; Xiao-chun Fei; Kun-wei Shen
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

7.  Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer.

Authors:  Stephanie J Gros; Nina Kurschat; Astrid Drenckhan; Thorsten Dohrmann; Evelyn Forberich; Katharina Effenberger; Uta Reichelt; Robert M Hoffman; Klaus Pantel; Jussuf T Kaifi; Jakob R Izbicki
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

8.  HER2 gene status in primary breast cancers and matched distant metastases.

Authors:  Coya Tapia; Spasenija Savic; Urs Wagner; René Schönegg; Hedvika Novotny; Bruno Grilli; Michelle Herzog; Audrey Devito Barascud; Inti Zlobec; Gieri Cathomas; Luigi Terracciano; Georg Feichter; Lukas Bubendorf
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.